White House Bars Politico, CNN, MS NOW Reporters

The White House barred Politico, CNN and MS NOW reporters from the presidential complex Saturday, escalating President Donald Trump’s fight with the press into a direct access fight that raises fresh First Amendment risks and could trigger more legal and political blowback.

Trump White House access talk and media stocks

Trump said the number of media outlets denied access to the White House could be expanded, a move that would escalate his long-running battle with the press and sharpen the economic stakes for companies that depend on political coverage, advertising reach and access-driven journalism.

White House backs $1.6 trillion COVID relief offer

The White House has raised the stakes in last-ditch COVID relief talks by backing a $400-a-week unemployment benefit and floating a $1.6 trillion package, a sign that Washington still wants to blunt the pandemic’s economic damage even as the negotiations themselves look increasingly likely to fail.

Canada Counter-Tariffs Hit U.S. Trade and Politics

Canada’s counter-tariffs on roughly 700 American goods are turning a trade dispute into a political and economic test for Washington, with a former White House official warning the retaliation could create “real political problems” for Republicans if the pain spreads through exporters, farmers and manufacturers in key states.

White House pushes drug pricing after strong jobs data

The White House is using Labor Day to frame a political and economic message that matters to investors: U.S. hiring is still holding up, while the administration is leaning harder into drug-pricing pressure that could reshape margins across the health-care supply chain.

White House Games Push Trump Agenda Into Gaming

The White House’s launch of video games promoting President Donald Trump’s agenda turns a campaign-style messaging tool into a new front in political persuasion, with implications for how government communication reaches younger voters and for an industry already sensitive to platform control and regulation.

Eli Lilly and Novo Nordisk agree to lower U.S. drug prices

President Donald Trump’s most-favored-nation drug pricing push lands its biggest win yet, with Eli Lilly and Novo Nordisk agreeing to slash U.S. prices on blockbuster obesity and diabetes medicines and expand domestic manufacturing in a move that could reshape how Washington pays for prescription drugs.

Trump White House staff churn raises policy risk

A widening exodus of top White House aides is raising fresh questions about staff stability inside President Donald Trump’s second-term operation just as the Supreme Court clears the way for a new ballroom at the White House.

Europe defense spending lifts Lockheed, RTX, Northrop

Europe is being pushed to spend more on weapons as governments brace for a more volatile security order, and the clearest market beneficiary is the U.S. defense supply chain. A cabinet-approved 2027 budget that lifts defense spending to 3.01% of GDP underscores how quickly military outlays are becoming a structural rather than cyclical line item, with air defense and other high-end systems moving to the front of the queue.

SPY at 747.03 as socialist policy debate grows

A democratic socialist in the White House would matter far less for markets than the policies that could follow, and that is exactly why investors should pay attention to the growing activist energy behind the idea.